Advanced Filters
noise

Orbassano (To), Italy Clinical Trials

A listing of Orbassano (To), Italy clinical trials actively recruiting patients volunteers.

Found 64,920 clinical trials
L Lisa Salvatore, MD, PhD

Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the Colorectal Cancer (CRC).

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

18 - 85 years of age All Phase N/A
Y Yun-Jen Chou, PhD

Changes of Low Anterior Resection Syndrome and Balance Ability in Patients With Rectal Cancer.

The purposes of this study are to explore the trajectory of symptom distress and balance ability in patients with rectal cancer.

20 years of age All Phase N/A

The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments

The study will apply state of the art radiology through advanced magnetic resonance imaging (MRI) techniques to investigate structural and functional brain effects of electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS).

18 years of age All Phase N/A
N Nancy A Hantler, BS

Alzheimer"s Imaging Biomarkers in Obesity

High body fat at midlife, as evidenced by overweight or obese body mass index (BMI), is increasingly understood as a risk factor for Alzheimer's disease. However, the underlying processes and mechanisms that may underlie this risk remains unknown. With this project, the Investigator proposes to create a new cohort of …

40 - 60 years of age All Phase N/A
A Alberto Fabbri, MD

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).

70 years of age All Phase N/A
M Michele Piazza, Pr

The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA

To assess safety and feasebility of the "safe-line" technique in a multicenter international collaboration.

18 - 100 years of age All Phase N/A
R Romain ASMOLOV, MD

Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements

Non-invasive neuromonitoring tools such as transcranial doppler, optic nerve envelope diameter measurement and quantitative pupillometry are routinely used in acute brain injured patients as part of multimodal neuromonitoring with the aim, among others, of detecting episodes of intracranial hypertension, each method allowing the study of one of the different pathophysiological …

18 years of age All Phase N/A
D Debby Noble

Non-Invasive Testing to Evaluate Wound Healing in Diabetes

Data will be collected with 3 vascular imaging devices (IntraOx Vioptix, Newark, CA; Hyperview, HyperMed Imaging, Memphis, TN; Snapshot NIH, Kent Imaging, Calgary, Alberta, Canada). The wound will be imaged with the 3 devices at index research encounter (this will count as the initial pre-operative imaging if the patient requires …

18 - 89 years of age All Phase N/A
S Shin Yi Lin, MS

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.

Non-vitamin K antagonist oral anticoagulant (NOAC) is the first line therapy to prevent thromboembolism in atrial fibrillation (AF) patients. Previous investigation showed that preceding NOAC therapy was associated with lower severity of ischemic stroke, but with higher in-hospital mortality in intracerebral hemorrhage (ICH), as compared with antithrombotic agent non-users. Measurement …

20 years of age All Phase N/A
E Ed Lesofski, MS

Ketamine Treatment Plans for Chronic Conditions

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

18 years of age All Phase N/A

Simplify language using AI